Traditional Chinese medicine composition for treating dermatophytosis and bromhidrosis and application thereof
US-12090184-B2 · Sep 17, 2024 · US
Formulations for cathepsin K inhibitors
US8975296B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8975296-B2 |
| Application number | US-201313847794-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 20, 2013 |
| Priority date | May 14, 2008 |
| Publication date | Mar 10, 2015 |
| Grant date | Mar 10, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The instant invention relates to pharmaceutical compositions containing cathespin K inhibitors. Also disclosed are processes for making said pharmaceutical compositions.
First claim
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical composition comprising from 1% to 95% by weight of an amorphous cathepsin K inhibitor system and from 5% to 99% by weight of excipients comprising a diluent, a glidant, a lubricant, a surfactant and a disintegrant, wherein the amorphous cathepsin K inhibitor system comprises a cathepsin K inhibitor, which is N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide, and a poly…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8975296B2 cover?
- The instant invention relates to pharmaceutical compositions containing cathespin K inhibitors. Also disclosed are processes for making said pharmaceutical compositions.
- Who is the assignee on this patent?
- Merck Sharp & Dohme, Merck Sharp & Dohme
- What technology area does this patent fall under?
- Primary CPC classification A61K9/10. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).